A Study of the Safety and Pharmacokinetics of GDC-0152, Administered Intravenously to Patients With Locally Advanced or Metastatic Malignancies
Clinical trial NCT00977067 · TERMINATED
Trial details
- NCT number
- NCT00977067
- Sponsor
- Genentech, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2009-11-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.